Home Physical Sciences Poly[bis(dimethylformamide-κO)-(μ8-5,5′′-dicarboxy-[1,1′:4′,1′′-terphenyl]-2′,3,3′′,5′-tetracarboxylato-κ8O:O1:O2:O3:O4:O5:O6:O7)dizinc(II)] — dimethylformamide (1/2), C18H19N2O8Zn
Article Open Access

Poly[bis(dimethylformamide-κO)-(μ8-5,5′′-dicarboxy-[1,1′:4′,1′′-terphenyl]-2′,3,3′′,5′-tetracarboxylato-κ8O:O1:O2:O3:O4:O5:O6:O7)dizinc(II)] — dimethylformamide (1/2), C18H19N2O8Zn

  • Guoqiang Li ORCID logo , Guo Chen , Yanping Liu , Gao Wang and Liyu Liu EMAIL logo
Published/Copyright: May 7, 2020

Abstract

C18H19N2O8Zn, orthorhombic, Pbca (no. 61), a = 17.4714(12) Å, b = 10.9180(7) Å, c = 20.0697(14) Å, V = 3828.4(4) Å3, Z = 8, Rgt(F) = 0.0449, wRref(F2) = 0.1492, T = 100 K.

CCDC no.: 1985847

Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colorless block
Size:0.20 × 0.20 × 0.20 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:1.33 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω
θmax, completeness:25.0°, >99%
N(hkl)measured, N(hkl)unique, Rint:18620, 3373, 0.059
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2334
N(param)refined:264
Programs:SHELX [1], Bruker Programs [2]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C1−0.1409(2)0.0401(4)0.0251(3)0.0252(11)
C2−0.2165(2)0.0886(4)0.0498(2)0.0227(10)
C3−0.2159(3)0.1742(4)0.1004(3)0.0287(11)
H3−0.16890.19630.12100.034*
C4−0.2832(3)0.2277(4)0.1213(2)0.0275(11)
C5−0.2815(3)0.3209(5)0.1757(3)0.0406(14)
C6−0.3526(2)0.1917(4)0.0930(2)0.0232(10)
H6−0.39900.22860.10740.028*
C7−0.3540(2)0.1018(4)0.0437(2)0.0175(9)
C8−0.2854(2)0.0536(4)0.0214(2)0.0198(9)
H8−0.2855−0.0043−0.01400.024*
C9−0.4292(2)0.0523(4)0.0191(2)0.0173(9)
C10−0.4385(2)−0.0732(4)0.0139(2)0.0188(9)
H10−0.3962−0.12490.02350.023*
C11−0.4918(2)0.1266(4)0.0051(2)0.0173(9)
C12−0.4882(2)0.2651(4)0.0038(2)0.0168(9)
C130.0025(5)−0.1946(8)0.3043(4)0.093(3)
H13A−0.0168−0.25760.27380.140*
H13B−0.0379−0.17180.33580.140*
H13C0.0467−0.22660.32870.140*
C140.0573(5)0.0123(6)0.3039(3)0.069(2)
H14A0.08030.07200.27340.104*
H14B0.0966−0.01910.33430.104*
H14C0.01670.05210.32980.104*
C150.0199(3)−0.0824(5)0.2022(3)0.0365(12)
H15−0.0025−0.15050.18010.044*
C16−0.1629(5)0.2290(9)0.3636(6)0.126(4)
H16A−0.11680.18330.35110.188*
H16B−0.16400.24020.41200.188*
H16C−0.16230.30930.34170.188*
C17−0.3014(5)0.2106(8)0.3627(5)0.101(3)
H17A−0.30970.29030.34140.151*
H17B−0.30310.22020.41120.151*
H17C−0.34150.15350.34860.151*
C18−0.2246(5)0.0712(8)0.3025(5)0.091(3)
H18−0.27000.03550.28500.109*
N10.0255(3)−0.0873(4)0.2663(2)0.0440(12)
N2−0.2281(3)0.1636(4)0.3434(3)0.0486(13)
O1−0.08762(18)0.0348(3)0.06653(18)0.0356(9)
O2−0.13633(17)0.0137(3)−0.03536(19)0.0330(8)
O3−0.2205(2)0.3625(5)0.1961(3)0.0765(16)
O4−0.3469(2)0.3545(4)0.1990(2)0.0587(13)
H4−0.33980.40850.22990.088*
O5−0.51309(18)0.3214(3)0.05340(17)0.0264(7)
O6−0.46262(18)0.3108(3)−0.04835(17)0.0282(8)
O70.04164(19)0.0040(3)0.16738(17)0.0319(8)
O8−0.1574(4)0.0286(6)0.2860(4)0.115(2)
Zn10.02790(3)0.00792(4)0.06918(2)0.01817(19)

Source of material

Functional organic ligand [1,1′:4′,1′′-terphenyl]-2′,3,3′′,5,5′,5′′-hexacarboxylic acid (H6L) was purchased from Jinan Camolai Trading Company (China), and other reagents were of analytical grade and also commercially available and used as received. A mixture of H6L (98.9 mg, 0.2 mmol), Zn(CH3COO)2 ⋅ 2H2O (43.8 mg, 0.2 mmol) and 10 mL DMF were placed in a 15 mL Teflon-lined autoclave at 413 K for 3 days, then cooled to room temperature. Colorless block crystals were obtained in a yield of 52% (based on Zn).

Experimental details

The structure was solved by direct methods and refined using the SHELX software [1]. All hydrogen atoms were placed in the calculated positions.

Comment

Previously literature has confirmed that due to the degree of deprotonation, defines the number of metal centers each ligand is able to connect. The partially deprotonated H6L exhibits nine different coordination modes [3] and plays an important role in the construction of functional MOFs. Up to now, there are more than ten cases of MOFs with distinctive structures and photoluminescence properties have been self-assembled by Zn(NO3)2 and H6L through a systematic solvent-ratio-controlled or temperature-modulated solvothermal method [4], [5], [6]. In the present work, a novel 2D zinc framework was synthesized by utilizing H6L and zinc acetate dihydrate.

As shown in the upper view of the figure, the asymmetric unit of title compound consists of one Zn(II) atom, one half of an H6L ligand, one coordinated N,N-dimethylformamide and one additional N,N-dimethylformamide molecule. In the structure, it can be seen that only four carboxyl groups of each ligand are deprotonized and connected with eight metal ions. Each Zn(II) centre is five coordinated by four oxygen atoms (O1, O2, O5 and O6) derived from four different L4− ligands and one oxygen atom (O7) derived from coordinated N,N-dimethylformamide molecule, resulting in a slightly distorted trigonal-bipyramid [ZnO5] coordination geometry. The bond angles around the Zn(II) atom vary from 86.29(13)° to 159.20(14)°, and the Zn-O bond distances range from 1.986(3) Å to 2.077(3) Å, which are consistent with the previously reported examples [7], [8]. Moreover, it is worth noting that the sum of three bond angles O5-Zn1-O7, O7-Zn1-O6, O6-Zn1-O5 is exactly 360°, demonstrating the O5, O6 and O7 atoms are highly coplanar.

As seen from the lower view of the figure (all solvent molecules and hydrogen atoms have been omitted), although the O3 and O4 atoms in each ligand are not involved in coordination, the Zn (II) center adopts the above coordination modes to connect with four adjacent ligands, forming a 2D network (perpendicular to the c-axis) with the DMF molecules in the gaps.

References

1. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed

2. Bruker. APEX2, SAINT. BRUKER AXS Inc. Madison, Wi, USA (2007).Search in Google Scholar

3. Wan, X. Y.; Jiang, F. L.; Chen, L.; Wu, M. Y.; Zhang, M. J.; Pan, J.; Su, K. Z.; Yang, Y.; Hong, M. C.: Structural diversity modulated by the ratios of a ternary solvent mixture: syntheses, structures, and luminescent properties of five zinc(II) metal-organic frameworks. Cryst. Growth Des. 15 (2015) 1481–1491.10.1021/cg501828uSearch in Google Scholar

4. Gao, X. C.; Chang, S. Y.; Liu, H. T.; Liu, Z. L.; A promising white-light-emitting material constructed from encapsulating Eu3+/Tb3+ hybrid ions into a robust microporous metal-organic framework. Eur. J. Inorg. Chem. 17 (2016) 2837–2842.10.1002/ejic.201501431Search in Google Scholar

5. Wan, X. Y.; Jiang, F. L.; Chen, L.; Pan, J.; Zhou, K.; Su, K. Z.; Pang, J. D.; Lyu, G. X.; Hong, M. C.: Structural variability, unusual thermochromic luminescence and nitrobenzene sensing properties of five Zn(II) coordination polymers assembled from a terphenyl-hexacarboxylate ligand. CrystEngComm 15 (2015) 3829–3837.10.1039/C5CE00420ASearch in Google Scholar

6. Wan, X. Y.; Jiang, F. L.; Liu, C. P.; Zhou, K.; Chen, L.; Gai, Y. L.; Yang, Y.; Hong, M. C.: Rapid and discriminative detection of nitro aromatic compounds with high sensitivity using two zinc MOFs synthesized through a temperature-modulated method. J. Mater. Chem. A 3 (2015) 22369–22376.10.1039/C5TA04552ESearch in Google Scholar

7. Xiao, Z. Y.; Wang, Y. T.; Zhang, S. Y.; Fan, W. D.; Xin, X. L.; Pan, X. L.; Zhang, L. L.; Sun, D. F.: Stepwise synthesis of diverse isomer MOFs via metal-ion metathesis in a controlled single-crystal-to-single-crystal transformation. Cryst. Growth Des. 17 (2017) 4084–4089.10.1021/acs.cgd.7b00118Search in Google Scholar

8. Sheng, D. H.; Zhang, Y.; Han, Y.; Xu, G.; Song, Q. X.; Hu, Y. P.; Liu, X. Y.; Shan, D. M.; Cheng, A. C.: A zinc(II) metal-organic framework with high affinity for CO2 based on triazole and tetrazolyl benzene carboxylic acid. CrystEngComm 21 (2019) 3679–3685.10.1039/C9CE00513GSearch in Google Scholar

Received: 2020-03-03
Accepted: 2020-04-06
Published Online: 2020-05-07
Published in Print: 2020-08-26

©2020 Guoqiang Li et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. Crystal structure of isopimara-7,15-dien-3-one, C20H30O
  3. Crystal structure of bis(6-aminopyridine-2-carboxylato-κ2O,N)-copper(II), C12H10O6N4Cu
  4. Crystal structure of 5,6-diphenyldibenzo[c, g]chrysene, C38H24
  5. Poly[bis(dimethylformamide-κO)-(μ8-5,5′′-dicarboxy-[1,1′:4′,1′′-terphenyl]-2′,3,3′′,5′-tetracarboxylato-κ8O:O1:O2:O3:O4:O5:O6:O7)dizinc(II)] — dimethylformamide (1/2), C18H19N2O8Zn
  6. The crystal structure of poly[bis(N,N-dimethylformamide-κ1O)(μ4- 2′,5,5′,5′′-tetracarboxy-[1,1′:4′,1′′-terphenyl]-3,3′′-dicarboxylato-κ4O:O′:O′′:O′′′)manganese(II)] — N,N-dimethylformamide (1/2), C36H40N4O16Mn
  7. Crystal structure of N,N-dimethyl-4-((7-nitrobenzo[c][1,2,5]thiadiazol-4-yl)ethynyl)aniline, C16H12N4O2S
  8. The crystal structure of 8a-methoxy 8a-methoxy-1,5,8a,9a-tetrahydro-4H-8,9-dioxa-3a1λ4-aza-8aλ4, C18H14BNO3
  9. Crystal structure of poly[diaqua-(μ2-5-isopropoxyisophthalato-κ2O:O′)-(μ2-(1,3-bis(3,5-di(1H-imidazol-1-yl)pyridine))-κ2N:N′)cobalt(II)] monohydrate, C22H25N5O8Co
  10. The crystal structure of acetoximium 1′-hydroxy-1H,1H′-5,5′-bitetrazole-1-olate monohydrate, C5H11N9O4
  11. Crystal structure of 3-(2-ethoxy-2-oxoethyl)-1-vinyl-1H-imidazol-3-ium hexafluoridophosphate(V), C9H13F6N2O2P
  12. The crystal structure of catena-poly[(μ2-4-(benzo[d]imidazol-2-yl)benzenecarboxylato-κ2N,O)-(μ2-4-(benzo[d]imidazol-2-yl)benzenecarboxylato-κ3N,O:O′)cadmium(II)]dihydrate, C28H22CdN4O6
  13. Enzyme-mediated synthesis and crystal structure of (2R,4S)-hydroxyketamine, C13H16ClNO2
  14. The crystal structure of bis(isothiocyanato-κ1N)-(methanol-κ1O)-[2-morpholine-4-yl-4,6-di(pyrazol-1-yl)-1,3,5-triazine-κ3N,N′,N′′] manganese(II), C16H18MnN10O2S2
  15. Crystal structure of bis{5-chloro-2-(((4-trifluoromethyl)imino)methyl)phenolato-κ2N,O}copper(II), C28H16Cl2CuF6N2O2
  16. Crystal structure of bis(1,3-phenylenedimethanaminium) bis(triiodide) tetraiodide – water (1/2) , C8H16I5N2O
  17. Crystal structure and anti-inflammatory activity of (3E,5E)-3,5-bis(2-fluorobenzylidene)-1-((4-fluorophenyl)sulfonyl)piperidin-4-one, C25H18F3NO3S
  18. The crystal structure of bis{3-(diphenylphosphaneyl)propanoato-κ2O,P}platinum(II) dihydrate, C30H28O6P2Pt
  19. The crystal structure of (E)-2-(4-((4-fluorobenzyl)oxy)styryl)-4,6-dimethoxybenzaldehyde, C24H21FO4
  20. Crystal structure of bis[3-methoxy-N-(1-(pyrazin-2-yl)ethylidene)benzohydrazonato-κ3O,N,N′]nickel(II), C28H26N8O4Ni
  21. Crystal structure of 1-(2-(pyridin-2-yl)-5-(pyridin-3-yl)-1,3,4-oxadiazol-3(2H)-yl)ethan-1-one, C14H12N4O2
  22. Synthesis and crystal structure of 3-N-acetyl-5-(pyridin-3-yl)-2-(quinolin-2-yl)-1,3,4-oxadiazoline, C18H14N4O2
  23. Crystal structure of 2-methyl-1H-perimidine, C12H10N2
  24. Crystal structure of (E)-2-(5,5-dimethyl-3-(4-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)oxy)styryl)cyclohex-2-en-1-ylidene)malononitrile, C25H19N5O4
  25. Structural elucidation of 1-(3-acetyl-2,6-dihydroxy-4-methoxyphenyl)-4,5-dihydroxy-2-methylanthracene-9,10-dione isolated from Bulbine latifolia (L.) Wild, C24H18O8
  26. Crystal structure of 3-cinnamoyl-4-hydroxybenzoic acid, C16H12O4
  27. The crystal structure of poly[bis(μ4-2,3-pyridinedicarboxylato)-(μ2-oxalyl dihydrazide)-dicadmium(II) dihydrate], C16H16O12N6Cd2
  28. Synthesis and crystal structure of 1-{4-[(3-bromo-2-hydroxy-benzylidene)amino]phenyl}ethanone, C15H12BrNO2
  29. Synthesis and crystal structure of 1-{4-[(2-bromo-6-hydroxy-benzylidene)amino]phenyl}ethanone, C15H12BrNO2
  30. Crystal structure of (4-aminobenzoato-κ2O,O′)-[5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ4N,N′,N′′,N′′′]nickel(II) perchlorate monohydrate, C23H44ClN5NiO7
  31. Crystal structure of 1-{4-[(4-fluoro-2-hydroxy-benzylidene)amino]phenyl}ethanone, C15H12FNO2
  32. Preparation and crystal structure of a non-symmetrical vanadium(II) dimer: tri-μ2-bromido-(hydrogen-tris(3-isopropyl-4-bromopyrazol-1-yl)borato-κ3N,N′,N′′)-tris(tetrahydrofuran-κO)divanadium(II) – tetrahydrofuran (1/1), C34H57BBr6N6O4V2
  33. Crystal structure of bis{2-(((4-(1-(hydroxyl-imino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}cobalt(II), C30H26CoN4O4
  34. Crystal structure of 3-((3-nitrophenyl)sulfonamido)propanoic acid — 4,4′-bipyridine (1/1), C19H18N4O6S
  35. Crystal structure of cyclo[diaqua-bis(μ2-3′,5-dicarboxy-[1,1′-biphenyl]-3,4′-dicarboxylato-κ4O,O′:O′′,O′′′)-bis(4,4′-bis(pyrid-4-yl)biphenyl-K1N)dicadmium(II)], C76H52Cd2N4O18
  36. Crystal structure of 1-(adamantan-1-yl)-3-aminothiourea, C11H19N3S
  37. Crystal structure of catena-poly[triaqua-(μ2-1,4-di(pyridin-4-yl)benzene-κ2N:N′)-(3′,5-dicarboxy-[1,1′-biphenyl]-3,4′-dicarboxylato-κO)nickel(II)], C32H26N2O11Ni
  38. Crystal structure of catena-poly[aqua-(μ4-4,4′-(pyridine-3,5-diyl)dibenzoato-κ4O,O′:O′′:O′′′)zinc(II)], C19H13NO5Zn
  39. Crystal structure of 4-(4′-(pyridin-4-yl)-[1,1′-biphenyl]-4-yl)pyridin-1-ium 2-carboxy-4-(3,5-dicarboxyphenoxy)benzoate hydrate, C38H28N2O10
  40. Crystal structure of 3-[(triisopropylsilanyl)-ethynyl]-6a,12a-dihydro-1H-1,4-diaza-benzo[α]anthracene-2,7,12-trione, C27H28N2O3Si
  41. Crystal structure of [(bis(1,10-phenanthroline-κ2N,N′)-(2-carboxy-4-(3-carboxy-5-carboxylatophenoxy)benzoato-κ2O:O′))nickel(II) monohydrate, (1,10-phenanthroline-κ2N:N′)-(μ2-(5-(3′,4′-dicarboxylphenoxy)-isophthalate-κ2O:O′))nickel(II)], C40H24N4O9Ni ⋅ H2O
  42. Crystal structure of 4-(3-(pyridin-3-yl)ureido)benzoic acid — adipic acid (2/1), C16H16N3O5
  43. Crystal structure of poly[bis{μ2-5-carboxy-4′-methyl-[1,1′-biphenyl]-3-carboxylato-κ2O:O′}-{μ2-4,4′-bipyridine-κ2N:N′}]cobalt(II), C40H30N2O8Co
  44. Crystal structure of aqua-(2,2′-bipyridine-κ2N,N′)(((3-nitrophenyl)sulfonyl)glycine-κ2N,O)copper(II) dihydrate, C18H20CuN4O9S
  45. Crystal structure of bis{2-bromo-6-(((4-(1-(methoxyimino)ethyl)phenyl)imino)methyl)phenolato-κ2N,O}copper(II), C32H28Br2CuN4O4
  46. Crystal structure of bis(2-(2-((2,6-dichlorophenyl)amino)phenyl)acetato-κ2O,O′)-(1,10-phenanthroline-κ2N,N′)zinc(II), C40H28Cl4N4O4Zn
  47. Crystal structure of 2-(3,6-dimethyl-2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)-2-oxoethyl acetate, C14H17NO4
  48. Crystal structure of poly[dibromido-bis(μ2-1,6-di(1H-imidazol-1-yl)hexane-κ2N:N′)cadmium(II)], C24H36Br2N8Cd
  49. Synthesis and crystal structure of ((6R,7S)-3-ethyl-6-phenyl-6,7-dihydro-5H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazin-7-yl)(phenyl)methanone hemihydrate, 2(C19H18N4OS) ⋅ H2O
  50. Crystal structure of 2-(5-(pyridin-3-yl)-4-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)pyridine, C17H12N6
  51. The crystal structure of N-((1E,2E)-1,3-bis(4-fluorophenyl)but-2-en-1-ylidene)-4-methylbenzenesulfonamide, C23H19F2NO2S
  52. Crystal structure of diacetato-κ1O-diethanol-κ1O-bis(μ2-2-(((2-hydroxyethyl)imino)methyl)-5-methoxyphenolato-κ4O,N,O′:O′′)dinickel(II), C28H42Ni2N2O12
  53. The crystal structure of catena-poly[chlorido-(μ2-1,4-bis(pyridin-3-yl-methoxy)benzene-κ2N:N′)copper(II)], C18H16ClN2O2Cu
  54. N′,N′′′-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(methaneylylidene))bis(2-hydroxybenzohydrazide)nickel(II), C30H24N4NiO6
  55. Crystal structure of (E)-3′,6′-bis(ethylamino)-2′,7′-dimethyl-2-(2-((quinolin-2-ylmethylene)amino)ethyl)spiro[isoindoline-1,9′-xanthen]-3-one, C38H37N5O2
  56. Crystal structure of 4,4′-di(1H-imidazol-1-yl)-1,1′-biphenyl-1-ium 5,3′,5′-tricarboxy-[1,10-biphenyl]-2-carboxylate, C25H17N2O8
  57. The crystal structure of 1-carboxy-2-(1H-indol-3-yl)-N,N,N-trimethylethan-1-ammonium chloride, C14H19N2O2Cl
  58. The crystal structure of 5-bromo-2-fluoronicotinic acid monohydrate, C6H5BrFNO3
  59. Crystal structure of ethyl 3-(trifluoromethyl)-1H-pyrazole-4-carboxylate, C7H7F3N2O2
  60. Crystal structure of tetrakis(1H-benzo[d]imidazol-3-ium) bis(μ5-phenylphosphonato)-pentakis(μ2-oxido)-decaoxo-penta-molybdenum dihydrate, C40H42Mo5N8O23P2
  61. Structure of 7-(3,3,4,4,5,5-hexafluoro-2-(2-methylbenzo[b]thiophen-3-yl)cyclopent-1-en-1-yl)-8-methylquinoline, C24H15F6NS
  62. Crystal structure of monocarbonyl[2-((cyclopentylmethylene)amino)-5-methylphenolato-κ2N,O] (tricyclohexylphosphine)rhodium(I), C32H48NO2PRh
  63. The crystal structure of fac-tricarbonyl(1,10-phenanthroline-κ2N,N′)-(pyrazole-κN)rhenium(I)nitrate, C18H12O3N4Re
  64. Crystal structure of poly[diaqua-bis(μ2-4-(3-(pyridin-3-yl)-1H-1,2,4-triazol-5-yl)benzoato-κ2N:O)nickel(II)], C28H22O6N8Ni
  65. Crystal structure of 4,4′-bis(pyridin-1-ium-4-yl)biphenyl poly[bis(μ2-4,4′-bis(pyrid-4-yl)biphenyl-K2N:N′)-tetrakis(μ4-4′-methyl-[1,1′-biphenyl]-3,5-dicarboxylato-K4O,O′:O′′:O′′′)-bis[[μ2-1,1′-biphenyl]-3-carboxyl-5-carboxylato-K2O:O′]tetracobalt(II)]— [1,1′-biphenyl]-3,5-dicarboxylic acid (1/2), C93H68N3O16Co2
  66. The crystal structure of 4a-formyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydro-1-2-6a,6b,9,9,12a-heptamethylpicen-10-yl acetate, C32H50O3
  67. Crystal structure of 3,3′-(1,2-phenylenebis(methylene))bis(1-methyl-1H-imidazol-3-ium) bis(hexafluoridophosphate), C16H20F12N4P2
  68. Crystal structure of catena-poly[diaqua-(μ2-tartrato-κ4O,O′:O′′,O′′′)zinc(II)], C4H8O8Zn
  69. The crystal structure of (6aR,6bS,8aS,8bR,9S,11aS,12aS,12bS)-10-(4-acetoxy-3-methylbutyl)-6a,8a,9-trimethyl-3,4,5,6,6a,6b,7,8,8a,8b,9,10,11a,12,12a,12b-hexadecahydro-1H-naphtho[2′,1′:4,5]indeno[2,1-b]furan-4-yl acetate, C31H48O5
  70. Crystal structure of 4,4′-(oxybis(methylene))bis(bromobenzene), C14H12Br2O
  71. Crystal structure of (N,N-dimethylsulphoxide)-[N-(3-ethoxy-2-(oxide)benzylidene)-3-methoxybenzenecarbohydrazonato-κ3N,O,O′]-dioxo-molybdenum(VI), C19H22MoN2O7S
  72. Crystal structure of dichlorido-bis(dimethyl sulphoxide-κO)-bis(4-methylbenzyl-κC1)tin(IV), C20H30Cl2O2S2Sn
  73. Crystal structure of (E)-2-amino-N′-(2-hydroxy-4-(2-(piperidin-1-yl)ethoxy)benzylidene)benzohydrazide monohydrate, C21H26N4O3 ⋅ H2O
  74. Crystal structure of chloridotris(4-chlorophenyl)(dimethyl sulfoxide-κO)tin(IV), C20H18Cl4OSSn
  75. Crystal structure of catena{di-aqua-sodium-[N-(hydroxyethyl), N-isopropyl-dithiocarbamato]}n, [C6H16NNaO2S2]n
  76. Crystal structure of 2,2,4,4,6,6-hexakis(4-chlorophenyl)-1,3,5,2,4,6-trithiatristanninane, C36H24Cl6S3Sn3
  77. Crystal structure of 6-methoxy-3-(5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl)-4H-chromen-4-one-methanol (1/1), C20H18N2O6
  78. Crystal structure of hexanedihydrazide, C6H14N4O2
  79. Crystal structure of tert-butyl 2-(hydroxymethyl)-5-{4-[(methoxycarbonyl)amino]phenyl}-2,5-dihydro-1H-pyrrole-1-carboxylate, C18H24N2O5
  80. Crystal structure of [(Z)-O-isopropyl N-(4-nitrophenyl)thiocarbamato-κS]-(triphenylphosphine-κP)-gold(I), C28H26AuN2O3PS
  81. Crystal structure of [O-ethyl N-(4-nitrophenyl)thiocarbamato-κS](tri-4-tolylphosphine-κP)gold(I) tetrahydrofuran solvate, C30H30AuN2O3PS, C4H8O
Downloaded on 5.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2020-0117/html
Scroll to top button